APA

Farcasiu E., Ivanyi T., Mozejko-Pastewka B., Birkus Z., Csog J., Kowalska I., Coetzer T. F., Bulgurlu S., Schinzel B. & Kiljanski J. (20120313). Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study. : Clinical therapeutics.

Chicago

Farcasiu Eugenia, Ivanyi Tibor, Mozejko-Pastewka Barbara, Birkus Zita, Csog Jozsef, Kowalska Irina, Coetzer Thomas Frederic, Bulgurlu Sami, Schinzel Birgit and Kiljanski Jacek. 20120313. Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study. : Clinical therapeutics.

Harvard

Farcasiu E., Ivanyi T., Mozejko-Pastewka B., Birkus Z., Csog J., Kowalska I., Coetzer T. F., Bulgurlu S., Schinzel B. and Kiljanski J. (20120313). Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study. : Clinical therapeutics.

MLA

Farcasiu Eugenia, Ivanyi Tibor, Mozejko-Pastewka Barbara, Birkus Zita, Csog Jozsef, Kowalska Irina, Coetzer Thomas Frederic, Bulgurlu Sami, Schinzel Birgit and Kiljanski Jacek. Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study. : Clinical therapeutics. 20120313.